- Home
- KALA vs AZ Comparison
KALA vs AZ Comparison
Compare KALA & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KALA | AZ |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 228.5M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KALA | AZ |
|---|---|---|
| Price | $0.65 | $6.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $31.50 | $20.00 |
| AVG Volume (30 Days) | ★ 20.6M | 475.6K |
| Earning Date | 11-19-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,463,000.00 |
| Revenue This Year | N/A | $1,343,857.60 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 41.45 |
| 52 Week Low | $0.51 | $5.00 |
| 52 Week High | $20.60 | $12.36 |
Technical Indicators
Market Signals| Indicator | KALA | AZ |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 54.13 |
| Support Level | $0.57 | $5.64 |
| Resistance Level | $0.72 | $6.59 |
| Average True Range (ATR) | 0.09 | 0.51 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 39.53 | 67.68 |
Price Performance
Historical ComparisonAbout KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.